What Are the Signs of Richter’s Transformation?
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
CLL Global Virtual Town Hall: September 12, 2024
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
What CLL Patients Should Know About RSV and COVID Vaccines
Experts respond to a viewer question about vaccinations for COVID and RSV as it relates to people with CLL.
Is CLL Now a Highly Treatable Condition?
Dr. William Wierda and Dr. Patrick Reville discussed the long-term treatment and management of CLL.
Understanding Data from the TRANSCEND Trial | CAR T-Cell Therapy for CLL
Experts responded to viewer questions about CAR T-cell therapy during the Feb 7, 2024 virtual town hall.
How Is CLL Treatment Guided by Cytogenetic Testing?
Experts responded to viewer questions about CLL and cytogenetic testing during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Can Chronic Lymphocytic Leukemia (CLL) Be Inherited?
Experts responded to a viewer question about familial CLL during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
What’s Vital to Understand About MRD Status in CLL?
Experts responded to a viewer question about minimal residual disease during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
CLL Global Research Foundation | Research Updates
Dr. William Wierda discussed the latest research funded by the CLL Global Research Foundation during the Feb 7, 2024 virtual town hall.
How Do You Know When CLL Treatment Should Begin?
Experts responded to a viewer question about the CLL watch & wait period during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.